CanSino Biologics in talks with Russia, Brazil, Chile, Saudi Arabia to launch Phase III trial of its COVID-19 vaccine
Qiu Dongxu co-founder of CanSino said its new factory under construction in China will allow it to produce 100-200 million vaccine doses per year by early 2021.
Forget antibodies, scientists look towards T-cells in the immune system to fight Coronavirus infection
There is evidence that T-cells developed after exposure to other coronaviruses that cause the common cold could help fight off SARS-CoV-2.
Neanderthal genes passed down makes some people more prone to COVID-19 infection, a new study proposes
The Neanderthal gene was found highest in Bangladeshi ancestry, with 63 percent of its population carrying at least one copy of the risk variant.
Human challenge trials have been used to test other vaccines but there were rescue medicines to cure those who got sick. There is no cure for COVID-19.
Oxford's vaccine offers ‘good duration of immunity’ to COVID-19 compared to no vaccine: lead researcher
The vaccine has been licensed to AstraZeneca and is in its Phase III of its human trials in the UK.
The vaccine showed a “strong immune response” in animal studies and will begin human trials this month in over 1,000 subjects in multiple sites.
The researchers believe that patients with COVID-19 should be evaluated early for acute neurological changes.
Mathematical models use to predict severity of the COVID-19 in India carried elements of bias, assumptions: IJMR
Estimates of modelling studies are "only as good as" the validity of the epidemiological or statistical model used and accuracy of assumptions made for modelling.
The new research paper implied that coronavirus could enter the human brain through the nose and reach the olfactory bulb of the brain.
Roche’s arthritis drug Actemra fails to help patients with early-stage COVID-19 pneumonia in Italian study
I the study, Actemra did not reduce severe respiratory symptoms, intensive care visits, or death any better than standard treatments.
The new mask has a USB port that connects to a cellphone charger and heats the inner layer of carbon fibres to 70 degrees Celsius.
Flushing the toilet can fling a cloud of Coronavirus aerosols up to 91 centimetres into the air, infecting another user
Growing evidence shows that coronavirus can be passed not only through respiratory droplets but also through virus-laden faeces.
Japanese researchers find presence of COVID-19 in sewage plants, proves to be an early warning signal for transmission
Public health experts say such sampling of sewage could be used to estimate the number of infected people in a region without testing every individual.
The WHO lists 11 experimental coronavirus vaccines is currently being tested on humans, according to a table posted on its website.
FDA rescinds approval for use of hydroxychloroquine for COVID-19 patients, says risks outweighs the benefits
In a separate announcement, the FDA has warned doctors against prescribing the HCQ in combination with remdesivir, the other drug shown to help COVID-19 patients.
Coronavirus pandemic claims a new type of victims: Prestigious medical journals — The Lancet and New England Journal of Medicine
Journals used to take many months, or a year, to scrutinize and edit a complicated study, now peer review may be condensed to as little as 48 hours.
COVID-19 affects the nervous system of an infected individual, including the brain, spinal cord, nerves, and muscles
Nearly half of hospitalised patients have neurological manifestations like headache, disorders of smell and taste, seizures, strokes, and muscle pain.
More than 60 percent people believe China responded better to the Coronavirus pandemic than the US did
Only a third of the people surveyed, around the world, thought that the US had responded effectively to the pandemic.
Health ministry recommends tocilizumab, HCQ, plasma therapy for patients in the moderate stage of COVID-19
HCQ has demonstrated in-vitro activity against SARS-CoV-2 and shown to be clinically beneficial in several small single-centre studies with significant limitations.
ICMR denies claims that it published a study saying India's coronavirus cases could peak by mid-November
The news reports attributing this study to ICMR are misleading. This refers to a non peer reviewed modelling, not carried out by ICMR and does not reflect the official position of ICMR, said the agency